Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

566 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proteomic signature of HIV-associated subclinical left atrial remodeling and incident heart failure.
Peterson TE, Hahn VS, Moaddel R, Zhu M, Haberlen SA, Palella FJ, Plankey M, Bader JS, Lima JAC, Gerszten RE, Rotter JI, Rich SS, Heckbert SR, Kirk GD, Piggott DA, Ferrucci L, Margolick JB, Brown TT, Wu KC, Post WS. Peterson TE, et al. Among authors: kirk gd. Nat Commun. 2025 Jan 12;16(1):610. doi: 10.1038/s41467-025-55911-0. Nat Commun. 2025. PMID: 39800750 Free PMC article.
The Contribution of Socioeconomic Factors to HIV RNA Suppression in Persons With HIV Engaged in Care in the NA-ACCORD.
Chandran A, Feng X, Coburn SB, Kasaie P, Malone J, Horberg MA, Hogan B, Rebeiro PF, Gill MJ, McGinnis KA, Silverberg MJ, Karris MY, Napravnik S, Konkle-Parker D, Lee J, Freeman AM, Ghidey R, Garza V, Marconi VC, Kirk GD, Thorne J, Crane HM, Lang R, Kitahata MM, Moore RD, Althoff KN. Chandran A, et al. Among authors: kirk gd. J Acquir Immune Defic Syndr. 2024 Nov 1;97(3):232-241. doi: 10.1097/QAI.0000000000003486. J Acquir Immune Defic Syndr. 2024. PMID: 39431507
Prediction of differential Gag versus Env responses to a mosaic HIV-1 vaccine regimen by HLA class I alleles.
Nelson GW, van Duijn J, Yuki Y, Pau MG, Tomaka F, Lavreys L, DeRosa SC, McElrath MJ, Kirk GD, Michael NL, Haas DW, Deeks SG, Wolinsky S, Walker B, Barouch DH, Stieh D, Carrington M. Nelson GW, et al. Among authors: kirk gd. J Virol. 2024 Aug 20;98(8):e0028124. doi: 10.1128/jvi.00281-24. Epub 2024 Jul 24. J Virol. 2024. PMID: 39046263 Free PMC article. Clinical Trial.
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases.
Dhaenens BAE, Heimann G, Bakker A, Nievo M, Ferner RE, Evans DG, Wolkenstein P, Leubner J, Potratz C, Carton C, Iloeje U, Kirk G, Blakeley JO, Plotkin S, Fisher MJ, Kim A, Driever PH, Azizi AA, Widemann BC, Gross A, Parke T, Legius E, Oostenbrink R. Dhaenens BAE, et al. Among authors: kirk g. Neurooncol Pract. 2024 Jan 4;11(4):395-403. doi: 10.1093/nop/npae001. eCollection 2024 Aug. Neurooncol Pract. 2024. PMID: 39006526 Free PMC article.
566 results